25 XP   0   0   10

Inoviq Ltd
Buy, Hold or Sell?

Let's analyse Inoviq together

PenkeI guess you are interested in Inoviq Ltd. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Inoviq Ltd. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Inoviq Ltd

I send you an email if I find something interesting about Inoviq Ltd.

Quick analysis of Inoviq (30 sec.)










What can you expect buying and holding a share of Inoviq? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
A$0.21
Expected worth in 1 year
A$-0.16
How sure are you?
57.1%

+ What do you gain per year?

Total Gains per Share
A$-0.38
Return On Investment
-49.6%

For what price can you sell your share?

Current Price per Share
A$0.76
Expected price per share
A$0.695 - A$1.05
How sure are you?
50%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1. Valuation of Inoviq (5 min.)




Live pricePrice per Share (EOD)

A$0.76

Intrinsic Value Per Share

A$-0.87 - A$-0.76

Total Value Per Share

A$-0.65 - A$-0.54

2. Growth of Inoviq (5 min.)




Is Inoviq growing?

Current yearPrevious yearGrowGrow %
How rich?$12.8m$18.5m-$5.6m-44.2%

How much money is Inoviq making?

Current yearPrevious yearGrowGrow %
Making money-$5.8m-$4.2m-$1.6m-27.4%
Net Profit Margin-1,192.9%-2,354.1%--

How much money comes from the company's main activities?

3. Financial Health of Inoviq (5 min.)




4. Comparing to competitors in the Diagnostics & Research industry (5 min.)




  Industry Rankings (Diagnostics & Research)  


Richest
#100 / 152

Most Revenue
#133 / 152

Most Profit
#100 / 152

Most Efficient
#140 / 152
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

What can you expect buying and holding a share of Inoviq? (5 min.)

Welcome investor! Inoviq's management wants to use your money to grow the business. In return you get a share of Inoviq.

What can you expect buying and holding a share of Inoviq?

First you should know what it really means to hold a share of Inoviq. And how you can make/lose money.

Speculation

The Price per Share of Inoviq is A$0.76. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Inoviq.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Inoviq, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$0.21. Based on the TTM, the Book Value Change Per Share is A$-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.01 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Inoviq.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.06-8.4%-0.06-8.4%-0.13-17.1%-0.06-8.1%-0.05-6.4%
Usd Book Value Change Per Share-0.06-8.1%-0.06-8.1%-0.01-0.7%0.033.5%0.022.6%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.06-8.1%-0.06-8.1%-0.01-0.7%0.033.5%0.022.6%
Usd Price Per Share0.56-0.56-0.26-0.42-0.30-
Price to Earnings Ratio-8.72--8.72--1.97--5.70--4.23-
Price-to-Total Gains Ratio-9.01--9.01--46.98--10.33--6.66-
Price to Book Ratio3.99-3.99-1.27-2.39-2.38-
Price-to-Total Gains Ratio-9.01--9.01--46.98--10.33--6.66-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.498788
Number of shares2004
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.060.03
Usd Total Gains Per Share-0.060.03
Gains per Quarter (2004 shares)-124.0352.84
Gains per Year (2004 shares)-496.11211.36
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-496-5060211201
20-992-10020423412
30-1488-14980634623
40-1984-19940845834
50-2481-2490010571045
60-2977-2986012681256
70-3473-3482014801467
80-3969-3978016911678
90-4465-4474019021889
100-4961-4970021142100

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.07.00.00.0%0.07.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.07.00.0%0.00.07.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%4.03.00.057.1%4.03.00.057.1%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Fundamentals of Inoviq

About Inoviq Ltd

INOVIQ Ltd engages in the research, development, and commercialization of diagnostic and exosome-based products to enhance the diagnosis and treatment of cancer and other diseases in Australia and the United States. The company offers hTERT test, an immunocytochemistry test used as an adjunct to urine cytology testing for bladder cancer; and EXO-NET for capturing and isolating exosomes from liquid biopsy sample. Its cancer diagnostic pipeline includes blood tests in development for ovarian, breast, and other cancers. The company was formerly known as BARD1 Life Sciences Limited and changed its name to INOVIQ Ltd in December 2021. INOVIQ Ltd was incorporated in 1983 and is headquartered in Notting Hill, Australia.

Fundamental data was last updated by Penke on 2024-02-14 22:14:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is very efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.1. Profitability of Inoviq Ltd.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Inoviq earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Inoviq to the Diagnostics & Research industry mean.
  • A Net Profit Margin of -1,192.9% means that $-11.93 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Inoviq Ltd:

  • The MRQ is -1,192.9%. The company is making a huge loss. -2
  • The TTM is -1,192.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,192.9%TTM-1,192.9%0.0%
TTM-1,192.9%YOY-2,354.1%+1,161.2%
TTM-1,192.9%5Y-5,833.3%+4,640.5%
5Y-5,833.3%10Y-16,625.1%+10,791.8%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,192.9%-11.2%-1,181.7%
TTM-1,192.9%-14.5%-1,178.4%
YOY-2,354.1%-2.3%-2,351.8%
5Y-5,833.3%-8.3%-5,825.0%
10Y-16,625.1%-7.6%-16,617.5%
1.1.2. Return on Assets

Shows how efficient Inoviq is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Inoviq to the Diagnostics & Research industry mean.
  • -41.7% Return on Assets means that Inoviq generated $-0.42 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Inoviq Ltd:

  • The MRQ is -41.7%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -41.7%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-41.7%TTM-41.7%0.0%
TTM-41.7%YOY-21.2%-20.5%
TTM-41.7%5Y-33.3%-8.4%
5Y-33.3%10Y-92.8%+59.5%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-41.7%-1.8%-39.9%
TTM-41.7%-2.4%-39.3%
YOY-21.2%-1.5%-19.7%
5Y-33.3%-1.3%-32.0%
10Y-92.8%-1.7%-91.1%
1.1.3. Return on Equity

Shows how efficient Inoviq is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Inoviq to the Diagnostics & Research industry mean.
  • -45.7% Return on Equity means Inoviq generated $-0.46 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Inoviq Ltd:

  • The MRQ is -45.7%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -45.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-45.7%TTM-45.7%0.0%
TTM-45.7%YOY-23.0%-22.7%
TTM-45.7%5Y-37.1%-8.6%
5Y-37.1%10Y-193.7%+156.6%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-45.7%-0.3%-45.4%
TTM-45.7%-1.6%-44.1%
YOY-23.0%-0.9%-22.1%
5Y-37.1%-2.6%-34.5%
10Y-193.7%-3.0%-190.7%
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.2. Operating Efficiency of Inoviq Ltd.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Inoviq is operating .

  • Measures how much profit Inoviq makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Inoviq to the Diagnostics & Research industry mean.
  • An Operating Margin of -1,239.9% means the company generated $-12.40  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Inoviq Ltd:

  • The MRQ is -1,239.9%. The company is operating very inefficient. -2
  • The TTM is -1,239.9%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ-1,239.9%TTM-1,239.9%0.0%
TTM-1,239.9%YOY-2,919.3%+1,679.4%
TTM-1,239.9%5Y-6,682.6%+5,442.7%
5Y-6,682.6%10Y-4,773.3%-1,909.3%
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ-1,239.9%-27.5%-1,212.4%
TTM-1,239.9%-0.6%-1,239.3%
YOY-2,919.3%3.4%-2,922.7%
5Y-6,682.6%-1.8%-6,680.8%
10Y-4,773.3%-2.4%-4,770.9%
1.2.2. Operating Ratio

Measures how efficient Inoviq is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • An Operation Ratio of 0.06 means that the operating costs are $0.06 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Inoviq Ltd:

  • The MRQ is 0.059. The company is very efficient in keeping operating costs low. +2
  • The TTM is 0.059. The company is very efficient in keeping operating costs low. +2
Trends
Current periodCompared to+/- 
MRQ0.059TTM0.0590.000
TTM0.059YOY34.313-34.254
TTM0.0595Y68.710-68.651
5Y68.71010Y49.079+19.632
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0591.321-1.262
TTM0.0591.314-1.255
YOY34.3131.245+33.068
5Y68.7101.222+67.488
10Y49.0791.212+47.867
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.3. Liquidity of Inoviq Ltd.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Inoviq is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A Current Ratio of 6.20 means the company has $6.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Inoviq Ltd:

  • The MRQ is 6.195. The company is very able to pay all its short-term debts. +2
  • The TTM is 6.195. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.195TTM6.1950.000
TTM6.195YOY9.727-3.532
TTM6.1955Y8.935-2.740
5Y8.93510Y7.291+1.645
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ6.1952.415+3.780
TTM6.1952.276+3.919
YOY9.7272.635+7.092
5Y8.9352.810+6.125
10Y7.2912.851+4.440
1.3.2. Quick Ratio

Measures if Inoviq is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Inoviq to the Diagnostics & Research industry mean.
  • A Quick Ratio of 5.33 means the company can pay off $5.33 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Inoviq Ltd:

  • The MRQ is 5.331. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 5.331. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ5.331TTM5.3310.000
TTM5.331YOY9.523-4.192
TTM5.3315Y8.653-3.322
5Y8.65310Y7.092+1.561
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ5.3311.299+4.032
TTM5.3311.391+3.940
YOY9.5231.764+7.759
5Y8.6531.781+6.872
10Y7.0921.893+5.199
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

1.4. Solvency of Inoviq Ltd.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Inoviq assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Inoviq to Diagnostics & Research industry mean.
  • A Debt to Asset Ratio of 0.09 means that Inoviq assets are financed with 8.8% credit (debt) and the remaining percentage (100% - 8.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Inoviq Ltd:

  • The MRQ is 0.088. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.088. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.088TTM0.0880.000
TTM0.088YOY0.081+0.007
TTM0.0885Y0.098-0.010
5Y0.09810Y0.194-0.096
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0880.405-0.317
TTM0.0880.432-0.344
YOY0.0810.385-0.304
5Y0.0980.450-0.352
10Y0.1940.455-0.261
1.4.2. Debt to Equity Ratio

Measures if Inoviq is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Inoviq to the Diagnostics & Research industry mean.
  • A Debt to Equity ratio of 9.7% means that company has $0.10 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Inoviq Ltd:

  • The MRQ is 0.097. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.097. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.097TTM0.0970.000
TTM0.097YOY0.088+0.009
TTM0.0975Y0.109-0.013
5Y0.10910Y0.378-0.269
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
MRQ0.0970.537-0.440
TTM0.0970.563-0.466
YOY0.0880.595-0.507
5Y0.1090.697-0.588
10Y0.3780.743-0.365
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

2. Market Valuation of Inoviq Ltd

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Inoviq generates.

  • Above 15 is considered overpriced but always compare Inoviq to the Diagnostics & Research industry mean.
  • A PE ratio of -8.72 means the investor is paying $-8.72 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Inoviq Ltd:

  • The EOD is -7.797. Based on the earnings, the company is expensive. -2
  • The MRQ is -8.720. Based on the earnings, the company is expensive. -2
  • The TTM is -8.720. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-7.797MRQ-8.720+0.923
MRQ-8.720TTM-8.7200.000
TTM-8.720YOY-1.972-6.748
TTM-8.7205Y-5.705-3.016
5Y-5.70510Y-4.227-1.478
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-7.797-0.109-7.688
MRQ-8.720-0.341-8.379
TTM-8.720-0.303-8.417
YOY-1.972-0.228-1.744
5Y-5.705-0.347-5.358
10Y-4.2272.977-7.204
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Inoviq Ltd:

  • The EOD is -9.558. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -10.690. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -10.690. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-9.558MRQ-10.690+1.132
MRQ-10.690TTM-10.6900.000
TTM-10.690YOY-87.126+76.436
TTM-10.6905Y-64.127+53.438
5Y-64.12710Y-45.954-18.173
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD-9.558-0.732-8.826
MRQ-10.690-1.060-9.630
TTM-10.690-2.089-8.601
YOY-87.126-4.385-82.741
5Y-64.127-2.474-61.653
10Y-45.954-3.948-42.006
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Inoviq is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Diagnostics & Research industry mean).
  • A PB ratio of 3.99 means the investor is paying $3.99 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Inoviq Ltd:

  • The EOD is 3.565. Based on the equity, the company is fair priced.
  • The MRQ is 3.987. Based on the equity, the company is fair priced.
  • The TTM is 3.987. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD3.565MRQ3.987-0.422
MRQ3.987TTM3.9870.000
TTM3.987YOY1.268+2.719
TTM3.9875Y2.393+1.594
5Y2.39310Y2.382+0.011
Compared to industry (Diagnostics & Research)
PeriodCompanyIndustry (mean)+/- 
EOD3.5651.802+1.763
MRQ3.9871.941+2.046
TTM3.9872.143+1.844
YOY1.2683.098-1.830
5Y2.3933.541-1.148
10Y2.3824.010-1.628
2. Total Gains per Share
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Inoviq Ltd compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.094-0.0940%-0.008-91%0.040-335%0.030-410%
Book Value Per Share--0.2130.2130%0.307-31%0.197+8%0.143+49%
Current Ratio--6.1956.1950%9.727-36%8.935-31%7.291-15%
Debt To Asset Ratio--0.0880.0880%0.081+9%0.098-10%0.194-55%
Debt To Equity Ratio--0.0970.0970%0.088+10%0.109-12%0.378-74%
Dividend Per Share----0%-0%-0%-0%
Eps---0.097-0.0970%-0.198+103%-0.094-3%-0.074-24%
Free Cash Flow Per Share---0.080-0.0800%-0.004-94%-0.027-65%-0.026-67%
Free Cash Flow To Equity Per Share---0.082-0.0820%0.179-146%0.031-366%0.019-525%
Gross Profit Margin--1.0001.0000%1.084-8%1.021-2%1.015-1%
Intrinsic Value_10Y_max---0.756--------
Intrinsic Value_10Y_min---0.867--------
Intrinsic Value_1Y_max---0.038--------
Intrinsic Value_1Y_min---0.045--------
Intrinsic Value_3Y_max---0.143--------
Intrinsic Value_3Y_min---0.173--------
Intrinsic Value_5Y_max---0.282--------
Intrinsic Value_5Y_min---0.340--------
Market Cap69934215.040-12%78215898.40078215898.4000%35887294.560+118%58450280.781+34%42065693.257+86%
Net Profit Margin---11.929-11.9290%-23.541+97%-58.333+389%-166.251+1294%
Operating Margin---12.399-12.3990%-29.193+135%-66.826+439%-47.733+285%
Operating Ratio--0.0590.0590%34.313-100%68.710-100%49.079-100%
Pb Ratio3.565-12%3.9873.9870%1.268+214%2.393+67%2.382+67%
Pe Ratio-7.797+11%-8.720-8.7200%-1.972-77%-5.705-35%-4.227-52%
Price Per Share0.760-12%0.8500.8500%0.390+118%0.635+34%0.457+86%
Price To Free Cash Flow Ratio-9.558+11%-10.690-10.6900%-87.126+715%-64.127+500%-45.954+330%
Price To Total Gains Ratio-8.059+11%-9.014-9.0140%-46.979+421%-10.331+15%-6.659-26%
Quick Ratio--5.3315.3310%9.523-44%8.653-38%7.092-25%
Return On Assets---0.417-0.4170%-0.212-49%-0.333-20%-0.928+123%
Return On Equity---0.457-0.4570%-0.230-50%-0.371-19%-1.937+324%
Total Gains Per Share---0.094-0.0940%-0.008-91%0.040-335%0.030-410%
Usd Book Value--12873587.02012873587.0200%18568588.923-31%11888842.998+8%8622205.942+49%
Usd Book Value Change Per Share---0.062-0.0620%-0.005-91%0.026-335%0.020-410%
Usd Book Value Per Share--0.1400.1400%0.202-31%0.129+8%0.094+49%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.064-0.0640%-0.130+103%-0.062-3%-0.049-24%
Usd Free Cash Flow---4802042.748-4802042.7480%-270331.283-94%-1656746.787-65%-1590632.213-67%
Usd Free Cash Flow Per Share---0.052-0.0520%-0.003-94%-0.018-65%-0.017-67%
Usd Free Cash Flow To Equity Per Share---0.054-0.0540%0.117-146%0.020-366%0.013-525%
Usd Market Cap45897825.331-12%51333094.12051333094.1200%23552831.420+118%38360919.276+34%27607714.485+86%
Usd Price Per Share0.499-12%0.5580.5580%0.256+118%0.417+34%0.300+86%
Usd Profit---5886512.212-5886512.2120%-4275696.055-27%-4308220.314-27%-3491844.619-41%
Usd Revenue--493478.533493478.5330%181627.744+172%210524.107+134%151444.131+226%
Usd Total Gains Per Share---0.062-0.0620%-0.005-91%0.026-335%0.020-410%
 EOD+3 -5MRQTTM+0 -0YOY+11 -235Y+14 -2010Y+15 -19

3.2. Fundamental Score

Let's check the fundamental score of Inoviq Ltd based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-7.797
Price to Book Ratio (EOD)Between0-13.565
Net Profit Margin (MRQ)Greater than0-11.929
Operating Margin (MRQ)Greater than0-12.399
Quick Ratio (MRQ)Greater than15.331
Current Ratio (MRQ)Greater than16.195
Debt to Asset Ratio (MRQ)Less than10.088
Debt to Equity Ratio (MRQ)Less than10.097
Return on Equity (MRQ)Greater than0.15-0.457
Return on Assets (MRQ)Greater than0.05-0.417
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of Inoviq Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.137
Ma 20Greater thanMa 500.568
Ma 50Greater thanMa 1000.609
Ma 100Greater thanMa 2000.606
OpenGreater thanClose0.830
Total3/5 (60.0%)



Latest Balance Sheet

Balance Sheet of 2023-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets21,509
Total Liabilities1,893
Total Stockholder Equity19,615
 As reported
Total Liabilities 1,893
Total Stockholder Equity+ 19,615
Total Assets = 21,509

Assets

Total Assets21,509
Total Current Assets9,403
Long-term Assets12,105
Total Current Assets
Cash And Cash Equivalents 7,813
Net Receivables 280
Inventory 18
Total Current Assets  (as reported)9,403
Total Current Assets  (calculated)8,110
+/- 1,293
Long-term Assets
Property Plant Equipment 1,454
Intangible Assets 10,652
Long-term Assets  (as reported)12,105
Long-term Assets  (calculated)12,105
+/- 0

Liabilities & Shareholders' Equity

Total Current Liabilities1,518
Long-term Liabilities376
Total Stockholder Equity19,615
Total Current Liabilities
Accounts payable 467
Total Current Liabilities  (as reported)1,518
Total Current Liabilities  (calculated)467
+/- 1,051
Long-term Liabilities
Long term Debt Total 368
Other Liabilities 7
Long-term Liabilities  (as reported)376
Long-term Liabilities  (calculated)376
+/- 0
Total Stockholder Equity
Common Stock69,053
Retained Earnings -51,073
Other Stockholders Equity 1,635
Total Stockholder Equity (as reported)19,615
Total Stockholder Equity (calculated)19,615
+/- 0
Other
Capital Stock69,053
Cash And Equivalents7,813
Cash and Short Term Investments 7,813
Common Stock Shares Outstanding 92,019
Liabilities and Stockholders Equity 21,509
Net Invested Capital 19,615
Net Tangible Assets 8,964
Net Working Capital 7,886
Property Plant and Equipment Gross 2,687



Balance Sheet

Currency in AUD. All numbers in thousands.

 Trend2023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-30
> Total Assets 
727
1,453
7,627
7,374
33,522
30,779
21,509
21,50930,77933,5227,3747,6271,453727
   > Total Current Assets 
699
1,453
7,627
7,374
5,649
17,467
9,403
9,40317,4675,6497,3747,6271,453699
       Cash And Cash Equivalents 
650
1,446
7,557
7,327
4,999
15,395
7,813
7,81315,3954,9997,3277,5571,446650
       Short-term Investments 
17
0
0
0
0
0
0
00000017
       Net Receivables 
32
3
61
21
220
1,706
280
2801,7062202161332
       Other Current Assets 
0
0
0
0
383
353
0
03533830000
   > Long-term Assets 
0
0
0
0
27,873
13,313
12,105
12,10513,31327,8730000
       Property Plant Equipment 
0
0
0
0
1,727
1,647
1,454
1,4541,6471,7270000
       Goodwill 
0
0
0
0
11,031
11,031
0
011,03111,0310000
       Intangible Assets 
0
0
0
0
25,563
12,316
10,652
10,65212,31625,5630000
> Total Liabilities 
469
323
492
899
4,465
2,487
1,893
1,8932,4874,465899492323469
   > Total Current Liabilities 
459
301
463
876
1,459
1,796
1,518
1,5181,7961,459876463301459
       Short-term Debt 
0
0
0
0
347
357
0
03573470000
       Accounts payable 
0
0
428
799
605
1,020
467
4671,02060579942800
       Other Current Liabilities 
0
0
35
77
508
419
0
0419508773500
   > Long-term Liabilities 
0
0
29
23
3,006
691
376
3766913,006232900
       Long term Debt Total 
0
0
0
0
918
642
368
3686429180000
       Other Liabilities 
0
0
0
23
2,088
49
7
7492,08823000
> Total Stockholder Equity
258
1,130
7,135
6,475
29,057
28,293
19,615
19,61528,29329,0576,4757,1351,130258
   Common Stock
6,646
9,298
16,980
19,287
51,832
69,053
69,053
69,05369,05351,83219,28716,9809,2986,646
   Retained Earnings -51,073-30,176-25,171-12,828-9,575-8,125-6,349
   Capital Surplus 0000000
   Treasury Stock0000000
   Other Stockholders Equity 
-38
-43
-56
-63
1,216
-11,681
1,635
1,635-11,6811,216-63-56-43-38



Balance Sheet

Currency in AUD. All numbers in thousands.




Cash Flow

Currency in AUD. All numbers in thousands.




Income Statement

Currency in AUD. All numbers in thousands.


Latest Income Statement (annual, 2023-06-30)

Gross Profit (+$)
totalRevenue752
Cost of Revenue-44
Gross Profit707707
 
Operating Income (+$)
Gross Profit707
Operating Expense-0
Operating Income-8,969707
 
Operating Expense (+$)
Research Development3,224
Selling General Administrative5,054
Selling And Marketing Expenses0
Operating Expense08,279
 
Net Interest Income (+$)
Interest Income354
Interest Expense-60
Other Finance Cost-60
Net Interest Income354
 
Pretax Income (+$)
Operating Income-8,969
Net Interest Income354
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-8,969-10,122
EBIT - interestExpense = -9,382
-8,969
-8,910
Interest Expense60
Earnings Before Interest and Taxes (EBIT)-9,323-8,910
Earnings Before Interest and Taxes (EBITDA)-9,322
 
After tax Income (+$)
Income Before Tax-8,969
Tax Provision-0
Net Income From Continuing Ops-8,969-8,969
Net Income-8,969
Net Income Applicable To Common Shares-8,969
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,153-354
 

Technical Analysis of Inoviq
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Inoviq. The general trend of Inoviq is BULLISH with 28.6% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Inoviq's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (28.6%) Bearish trend (-28.6%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Inoviq Ltd.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.845 < 0.99 < 1.05.

The bearish price targets are: 0.775 > 0.7 > 0.695.

Tweet this
Inoviq Ltd Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Inoviq Ltd. The current mas is .

The long score for the Moving Averages is 9/14.
The longshort score for the Moving Averages is 4/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close > MA 20: The price is above the MA 20. +1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Inoviq Ltd Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Inoviq Ltd. The current macd is 0.03569849.

The long score for the Moving Average Convergence/Divergence (MACD) is 4/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 4/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Inoviq price going up in the near term. +2
  • MACD > 0: The MACD is above the zero line (centerline), it indicates a bullish signal for Inoviq. This means that the short-term moving average is higher than the long-term moving average, signaling positive momentum and suggesting a higher likelihood of the Inoviq price continuing to rise in the near future. It indicates that buyers are gaining control, and there is optimism in the market, leading to potential price increases. +1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Inoviq Ltd Daily Moving Average Convergence/Divergence (MACD) ChartInoviq Ltd Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Inoviq Ltd. The current adx is 36.79.

The long score for the Directional Movement Index (DMI) is 4/7.
The longshort score for the Directional Movement Index (DMI) is 4/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Inoviq shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bullish trend. The ADX is trending up, so the bullish trend is strengthening.
Inoviq Ltd Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Inoviq Ltd. The current sar is 0.60276271.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Inoviq Ltd Daily Parabolic SAR Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Inoviq Ltd. The current rsi is 70.14. The current phase is Overbought in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Overbought in bull market: Short-term excessive buying, potential for pullback. Consider taking profits, be cautious of potential correction. -1
  • Trending down: The RSI is trending down. -1
Inoviq Ltd Daily Relative Strength Index (RSI) ChartInoviq Ltd Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Inoviq Ltd. The current phase is Continuation in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH > 50: The STOCH %K is above 50. There are more buyers than sellers. +1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Inoviq price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Inoviq Ltd Daily Stochastic Oscillator ChartInoviq Ltd Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Inoviq Ltd. The current cci is 214.04.

The long score for the Commodity Channel Index (CCI) is 1/1.
The longshort score for the Commodity Channel Index (CCI) is 1/(-1 +1).

  • CCI > 100: The CCI is above 100, it indicates that the price is significantly above its average, suggesting a potential overbought condition. +1
Inoviq Ltd Daily Commodity Channel Index (CCI) ChartInoviq Ltd Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Inoviq Ltd. The current cmo is 47.21.

The long score for the Chande Momentum Oscillator (CMO) is 1/1.
The longshort score for the Chande Momentum Oscillator (CMO) is 1/(-1 +1).

  • CMO > 0: The CMO is above 0, the momentum of the price is positive, indicating a potential uptrend in the price. +1
Inoviq Ltd Daily Chande Momentum Oscillator (CMO) ChartInoviq Ltd Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Inoviq Ltd. The current willr is -37.64705882.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Inoviq is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Inoviq Ltd Daily Williams %R ChartInoviq Ltd Daily Williams %R Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Inoviq Ltd.

Inoviq Ltd Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Inoviq Ltd. The current atr is 0.05209743.

Inoviq Ltd Daily Average True Range (ATR) ChartInoviq Ltd Daily Average True Range (ATR) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Inoviq Ltd. The current obv is 518,564.

Inoviq Ltd Daily On-Balance Volume (OBV) ChartInoviq Ltd Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Inoviq Ltd. The current mfi is 76.41.

The long score for the Money Flow Index (MFI) is 1/2.
The longshort score for the Money Flow Index (MFI) is 1/(-2 +2).

  • MFI > 50: +1
Inoviq Ltd Daily Money Flow Index (MFI) ChartInoviq Ltd Daily Money Flow Index (MFI) Chart
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Inoviq Ltd.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-10-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-10-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-10-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-10-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-10-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-23STOCH SHORT EXITThe %K line crosses above the %D line.
2023-10-25DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-26SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-10-27STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-10-30STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-10-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-11-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-03STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-06MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-09STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-13CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-14STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-15CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-16STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-20MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-23CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-11-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-11-27MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-28SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-11-29MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-30MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-06STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-11STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-27STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-28STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-04WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-11DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-12WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-24STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-25MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-01-29RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-31RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-01STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-02RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-07STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-14CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-16CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-20ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-02-23ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE80 crossover to downside

6.3. Candlestick Patterns

Inoviq Ltd Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Inoviq Ltd based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5070.137
Ma 20Greater thanMa 500.568
Ma 50Greater thanMa 1000.609
Ma 100Greater thanMa 2000.606
OpenGreater thanClose0.830
Total3/5 (60.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Inoviq with someone you think should read this too:
  • Are you bullish or bearish on Inoviq? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Inoviq? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Inoviq Ltd

I send you an email if I find something interesting about Inoviq Ltd.


Comments

How you think about this?

Leave a comment
3rd Party Ad. No recommendation by Penke. PLUS is ad-free.

Stay informed about Inoviq Ltd.

Receive notifications about Inoviq Ltd in your mailbox!